Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | triprolidine | 5282443 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | triprolidine | 5282443 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | triprolidine | 5282443 | drug-path |
| Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | triprolidine | 5282443 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | triprolidine | 5282443 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | triprolidine | 5282443 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | Prestwick-674 | None | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | Prestwick-674 | None | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | Prestwick-674 | None | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | Prestwick-674 | None | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | Prestwick-674 | None | drug-path |
| Asthma | R-HSA-444620 | map05310 | Prestwick-674 | None | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | Prestwick-674 | None | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | Prestwick-674 | None | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | Prestwick-674 | None | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | Prestwick-674 | None | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | Prestwick-674 | None | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | Prestwick-674 | None | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | SR-95639A | 195164 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | SR-95639A | 195164 | drug-path |